What does Mirum Pharmaceuticals, Inc. do?
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that…
What is Mirum Pharmaceuticals, Inc.'s P/E and P/B ratio?
Mirum Pharmaceuticals, Inc. has a P/E ratio of -5.7 and a P/B ratio of -500.85.
What is Mirum Pharmaceuticals, Inc.'s debt-to-equity ratio?
Mirum Pharmaceuticals, Inc. has a debt-to-equity ratio of 1.02.
How much does Mirum Pharmaceuticals, Inc. owe compared with what it owns?
Mirum Pharmaceuticals, Inc. owes $1.01 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Mirum Pharmaceuticals, Inc.'s Positivity rank?
Mirum Pharmaceuticals, Inc. is ranked #6,754 of 6,775 companies globally and #3,981 of 3,999 in United States on PositoAI, with a Positivity Score of -270,487.
Does Mirum Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Mirum Pharmaceuticals, Inc..
Where can I read the latest news about Mirum Pharmaceuticals, Inc.?
Recent headlines about Mirum Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Mirum Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Mirum Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.